Ondansetron

Cleft lip with or without cleft palate

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S2852
R4648
Huybrechts (Control exposed to other treatment), 2018 Cleft lip and Cleft lip and palate 1st trimester retrospective cohort (claims database) exposed to other treatment, sick excluded Adjustment: No 0.93 [0.68;1.27] C
excluded (control group)
50/55,579   180/185,699 230 55,579
ref
S2844
R4649
Huybrechts (Unexposed control), 2018 Cleft lip and Cleft lip and palate 1st trimester retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: No 1.02 [0.82;1.28] C 81/88,446   1,545/1,727,925 1,626 88,446
ref
S2778
R3785
Fejzo (Mainly exposed to other treatements, sick), 2016 Cleft lip/palate 1st trimester retrospective cohort exposed to other treatment, sick excluded Adjustment: No 1.39 [0.06;34.20] C
excluded (control group)
1/952   0/441 1 952
ref
S2776
R3747
Fejzo (Unexposed control, disease free), 2016 Cleft lip/palate 1st trimester retrospective cohort unexposed, disease free Adjustment: No 0.68 [0.06;7.46] C 1/952   2/1,286 3 952
ref
S2746
R3895
Pasternak, 2013 Cleft lip with or without cleft palate 1st trimester population based cohort retrospective unexposed (general population or NOS) Adjustment: No 1.09 [0.30;3.92] C 3/1,233   11/4,932 14 1,233
ref
Total 3 studies 1.02 [0.82;1.27] 1,643 90,631
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Huybrechts (Unexposed control), 2018Huybrechts, 2018 1 1.02[0.82; 1.28]1,62688,44696%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Fejzo (Unexposed control, disease free), 2016Fejzo, 2016 2 0.68[0.06; 7.46]39521%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Pasternak, 2013Pasternak, 2013 1.09[0.30; 3.92]141,2333%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Total (3 studies) I2 = 0% 1.02[0.82; 1.27]1,64390,6310.25.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Unexposed control; 2: Unexposed control, disease free;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.02[0.82; 1.27]1,64390,6310%NAHuybrechts (Unexposed control), 2018 Fejzo (Unexposed control, disease free), 2016 Pasternak, 2013 3 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.02[0.82; 1.27]1,64390,6310%NAHuybrechts (Unexposed control), 2018 Fejzo (Unexposed control, disease free), 2016 Pasternak, 2013 3 Tags Adjustment   - No  - No 1.02[0.82; 1.27]1,64390,6310%NAHuybrechts (Unexposed control), 2018 Fejzo (Unexposed control, disease free), 2016 Pasternak, 2013 3 All studiesAll studies 1.02[0.82; 1.27]1,64390,6310%NAHuybrechts (Unexposed control), 2018 Fejzo (Unexposed control, disease free), 2016 Pasternak, 2013 30.25.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 2778, 2852

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.07[0.87; 1.32]2,34791,5170%NAZambelli-Weiner (Unexposed control, NOS), 2019 Huybrechts (Unexposed control), 2018 Fejzo (Unexposed control, disease free), 2016 Pasternak, 2013 4 unexposed, sick controlsunexposed, sick controls 0.98[0.77; 1.25]2,2387210%NAParker, BDS study, 2018 Parker, NBDPS study, 2018 Anderka, 2012 3 exposed to other treatment, sick controlsexposed to other treatment, sick controls 0.93[0.68; 1.27]23156,5310%NAHuybrechts (Control exposed to other treatment), 2018 Fejzo (Mainly exposed to other treatements, sick), 2016 20.510.01.0